Hewlett Packard Enterprise (HPE) Case Studies The Race to Deliver Global Cures
Edit This Case Study Record
Hewlett Packard Enterprise (HPE) Logo

The Race to Deliver Global Cures

Hewlett Packard Enterprise (HPE)
Infrastructure as a Service (IaaS) - Hybrid Cloud
Pharmaceuticals
Product Research & Development
Quality Assurance
Predictive Quality Analytics
Remote Collaboration
System Integration
Unichem Laboratories Ltd., a world-leader in the production of generic drugs, aims to lower the cost and widen the availability of life-saving treatments. The company wants to grow its existing business in North America and Europe while capitalizing on surging demand for pharma in emerging markets. It needs to do so in a way that is connected, collaborative, and efficient. Its strategy spans two fronts: the production of raw materials (APIs) for other manufacturers and the approval of new, generic drugs (ANDAs). The goal is to shorten the gap between discovery, approval, and production. The faster it can get innovation to market, the more lives will be saved or improved.
Read More
Unichem Laboratories Ltd. is one of the world’s largest pharmaceuticals producers. The Indian business manufactures, markets, and distributes more than 40 generic drugs in the U.S., from beta blockers to anti-allergens. Tramadol, the pain-relief drug, produced by Unichem, is arguably the best known. The company's revenues for 2020 were $154 million. The quicker it can win approval for new, generic drugs, the faster it can supply low-cost drug treatments to underserved and emerging markets.
Read More
Unichem's digital transformation is being driven from a hyperconverged infrastructure, creating a dynamic, scalable platform on which to grow. At the heart of Unichem's infrastructure is HPE SimpliVity. Today, some of Unichem's most critical applications run on HPE SimpliVity, including the business, quality, process, and document management systems. HPE SimpliVity has expanded from eight all-flash nodes at the Mumbai head office to include five additional all-flash nodes at the Goa R&D center. The six production sites will be included in the next phase of expansion. The catalyst was an upgrade to SAP EHP 8 and a desire to move from a UNIXR environment to Linux®.
Read More
Unichem now has an efficient and dynamic hyperconverged infrastructure from which to work.
The business is more secure, with strengthened continuity. Unichem suffered a ransomware attack in 2019, with systems down for several days. This threat no longer exists.
The business is also more mobile, and better connected. Today, Unichem's 300-strong R&D team can work from anywhere. Critical R&D apps such as Chromeleon, can be accessed remotely.
Accelerates innovation, enabling increase in ANDAs from 20 to 50 per year
Improves application recovery times, less than 60 seconds versus 48 hours
Stores 3.5 TB of virtual machine data in just 769 GB
Download PDF Version
test test